Literature DB >> 2619050

Genetic analysis of human deoxyribonuclease I by immunoblotting and the zymogram method following isoelectric focusing.

T Yasuda1, K Mizuta, Y Ikehara, K Kishi.   

Abstract

We have devised two independent detection methods for investigating possible molecular heterogeneity and genetic polymorphism in human DNase I, in terms of both its antigenicity and enzymatic activity. One was an immunoblotting method using an antibody specific to DNase I following polyacrylamide gel isoelectric focusing (IEF-PAGE). The DNase I-specific antibody was raised in a rabbit using purified enzyme from human urine as the immunogen. DNase I in urine was found to exist in multiple forms with different pI values separable by IEF-PAGE within a pH range of 3.5-4.0. This method was able to detect as little as 0.1 micrograms of the purified DNase I and facilitated classification of desialylated urine samples from different individuals into several groups according to differences in DNase I isozyme patterns. About 0.5 ml of the original urine was sufficient for analysis of the isozyme patterns. The other method was the zymogram method, which had a high sensitivity and resolution almost identical to those of the immunoblotting method for analysis of DNase I patterns. It was easier to perform, more time-saving, and more useful since it did not require antibody specific to DNase I. These two methods should prove valuable for biochemical and genetic analysis of DNase I isozymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619050     DOI: 10.1016/0003-2697(89)90175-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Genetic polymorphism of urine deoxyribonuclease I isomerases of subterranean mole rats, Spalax ehrenbergi superspecies, in Israel: ecogeographical patterns and correlates.

Authors:  E Nevo; K Kishi; A Beiles
Journal:  Biochem Genet       Date:  1990-12       Impact factor: 1.890

2.  Human serum deoxyribonuclease I (DNase I) polymorphism: pattern similarities among isozymes from serum, urine, kidney, liver, and pancreas.

Authors:  K Kishi; T Yasuda; Y Ikehara; K Sawazaki; W Sato; R Iida
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

3.  Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin.

Authors:  A M Otto; R Paddenberg; S Schubert; H G Mannherz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Two distinct secretory ribonucleases from human cerebrum: purification, characterization and relationships to other ribonucleases.

Authors:  T Yasuda; D Nadano; H Takeshita; K Kishi
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

5.  Rabbit DNase I: purification from urine, immunological and proteochemical characterization, nucleotide sequence, expression in tissues, relationships with other mammalian DNases I and phylogenetic analysis.

Authors:  T Yasuda; H Takeshita; T Nakajima; O Hosomi; Y Nakashima; K Kishi
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

6.  Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures.

Authors:  G Schumann; L Qin; A Rein; G Natsoulis; J D Boeke
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Discovery of a genetic polymorphism of human plasma protein C inhibitor (PCI): genetic survey utilizing isoelectric focusing followed by immunoblotting, immunological and biochemical characterization.

Authors:  T Yasuda; D Nadano; R Iida; Y Tanaka; M Nakanaga; K Kishi
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

8.  Structural insights into catalytic and substrate binding mechanisms of the strategic EndA nuclease from Streptococcus pneumoniae.

Authors:  Andrea F Moon; Marika Midon; Gregor Meiss; Alfred Pingoud; Robert E London; Lars C Pedersen
Journal:  Nucleic Acids Res       Date:  2010-11-26       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.